(Q46842382)

25 December 2017

title

Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension (English)

1 reference

25 December 2017

5

Eric Boerwinkle

1 reference

25 December 2017

Vincent J Canzanello

1

1 reference

25 December 2017

Evelyn Baranco-Pryor

2

1 reference

25 December 2017

Frederic Rahbari-Oskoui

3

1 reference

25 December 2017

Gary L Schwartz

4

1 reference

25 December 2017

Stephen T Turner

6

1 reference

25 December 2017

Arlene B Chapman

7

1 reference

25 December 2017

language of work or name

1 reference

1 January 2008

1 reference

25 December 2017

Journal of Clinical Hypertension

published in

1 reference

25 December 2017

volume

21

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

61-66

1 reference

25 December 2017

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Genetics of blood pressure, hypertensive complications, and antihypertensive drug responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Searching out low renin patients: limitations of some commonly used methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Systematic review: antihypertensive drug therapy in black patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: A primary role for beta blocking drugs such as propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Altered pharmacokinetics and excessive hypotensive effect of candesartan in a patient with the CYP2C9*1/*3 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

Detection and control of high blood pressure in the community : Do we need a wake-up call?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

7 January 2021

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

7 January 2021

Overlap between whites and blacks in response to antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

7 January 2021

Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

7 January 2021

Gender differences in the renal response to renin-angiotensin system blockade

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

7 January 2021

Optimisation of antihypertensive treatment by crossover rotation of four major classes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

7 January 2021

Individual responses to converting enzyme inhibitors and calcium antagonists

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

7 January 2021

CYP2C9*3 influences the metabolism and the drug-interaction of candesartan in vitro

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.24

7 January 2021

Identifiers

DOI

10.1038/AJH.2007.24

1 reference

25 December 2017

1 reference

25 December 2017